help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2007.061083 on July 19, 2007

Published online before print July 19, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2007.061083v1
171/3/938    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, Z.
Right arrow Articles by Aigner, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, Z.
Right arrow Articles by Aigner, T.
(American Journal of Pathology. 2007;171:938-946.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.061083

Activation of Interleukin-1 Signaling Cascades in Normal and Osteoarthritic Articular Cartilage

Zhiyong Fan*, Stephan Söder{dagger}, Stephan Oehler{ddagger}, Katrin Fundel§ and Thomas Aigner{dagger}

From the Department of Pathology,* University of Erlangen, Erlangen; the Institute of Pathology,{dagger} University of Leipzig, Leipzig; the Orthopedic Hospital,{ddagger} Rummelsberg, Schwarzenbruck; and the Institute for Informatics,§ Ludwig-Maximilians-Universität München, München, Germany

Interleukin (IL)-1 is one of the most important catabolic cytokines in rheumatoid arthritis. In this study, we were interested in whether we could identify IL-1 expression and activity within normal and osteoarthritic cartilage. mRNA expression of IL-1ß and of one of its major target genes, IL-6, was observed at very low levels in normal cartilage, whereas only a minor up-regulation of these cytokines was noted in osteoarthritic cartilage, suggesting that IL-1 signaling is not a major event in osteoarthritis. However, immunolocalization of central mediators involved in IL-1 signaling pathways [38-kd protein kinases, phospho (P)-38-kd protein kinases, extracellular signal-regulated kinase 1/2, P-extracellular signal-regulated kinase 1/2, c-Jun NH2-terminal kinase 1/2, P-c-Jun NH2-terminal kinase 1/2, and nuclear factor {kappa}B] showed that the four IL-1 signaling cascades are functional in normal and osteoarthritic articular chondrocytes. In vivo, we found that IL-1 expression and signaling mechanisms were detectible in the upper zones of normal cartilage, whereas these observations were more pronounced in the upper portions of osteoarthritic cartilage. Given these expression and distribution patterns, our data support two roles for IL-1 in the pathophysiology of articular cartilage. First, chondrocytes in the upper zone of osteoarthritic articular cartilage seem to activate catabolic signaling pathways that may be in response to diffusion of external IL-1 from the synovial fluid. Second, IL-1 seems to be involved in normal cartilage tissue homeostasis as shown by identification of baseline expression patterns and signaling cascade activation.




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. Megias, M. I. Guillen, A. Bru, F. Gomar, and M. J. Alcaraz
The Carbon Monoxide-Releasing Molecule Tricarbonyldichlororuthenium(II) Dimer Protects Human Osteoarthritic Chondrocytes and Cartilage from the Catabolic Actions of Interleukin-1{beta}
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 56 - 61.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.